Yonsei Medical Journal · 2015 · 44 citations · 34 references
MedicineClinical SciencesInternal MedicineGastroenterologyHepatologyNutritional EpidemiologyFunctional Gastrointestinal DisordersGastrointestinal DiseaseHepatic PathophysiologyIrritable Bowel SyndromeLiver DiseaseMetabolic SyndromeGamma-glutamyl TransferaseHepatic Enzyme AlterationsIrritable Bowel Syndrome ComorbidityIrritable Bowel Syndrome PathophysiologyLiver Enzyme AbnormalitiesRome CriteriaSerum Alanine AminotransferaseSerum Aspartate Aminotransferase
PURPOSE: Recent studies have revealed close relationships between hepatic injury, metabolic pathways, and gut microbiota. The microorganisms in the intestine also cause irritable bowel syndrome (IBS). The aim of this study was to examine whether IBS was associated with elevated hepatic enzyme [alanine aminotransferase (ALT) and aspartate aminotransferase (AST)], gamma-glutamyl transferase (γ-GT) levels, and metabolic syndrome (MS). MATERIALS AND METHODS: This was a retrospective, cross-sectional, case-control study. The case and control groups comprised subjects who visited our health promotion center for general check-ups from June 2010 to December 2010. Of the 1127 initially screened subjects, 83 had IBS according to the Rome III criteria. The control group consisted of 260 age- and sex-matched subjects without IBS who visited our health promotion center during the same period. RESULTS: Compared to control subjects, patients with IBS showed significantly higher values of anthropometric parameters (body mass index, waist circumference), liver enzymes, γ-GT, and lipid levels. The prevalences of elevated ALT (16.9% vs. 7.7%; p=0.015) and γ-GT (24.1% vs. 11.5%; p=0.037) levels were significantly higher in patients with IBS than in control subjects. A statistically significant difference was observed in the prevalence of MS between controls and IBS patients (12.7% vs. 32.5%; p<0.001). The relationships between elevated ALT levels, MS, and IBS remained statistically significant after controlling for potential confounding factors. CONCLUSION: On the basis of our study results, IBS may be an important condition in certain patients with elevated ALT levels and MS.
34
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Patrice D. Cani, Jacques Amar, Miguel A. Iglesias et al. · Diabetes · 2007 · 6.4K citations · Full text
S. J. Creely, Philip G. McTernan, Christine M. Kusminski et al. · American Journal of Physiology-Endocrinology and Metabolism · 2006 · 1K citations